Abstract
The signaling lymphocytic activation molecule (SLAM) family is a group of six receptors restricted to hematopoietic cells. Most of these receptors are self-ligands, and thus are triggered in the context of interactions between hematopoietic cells. By way of their cytoplasmic domain, SLAM-related receptors associate with the SLAM-associated protein (SAP) family of adaptors, which control the signals and functions of SLAM family receptors. Recent findings have provided new insights into the key roles of SLAM family receptors in normal immunity, their involvement in human diseases and their usefulness as drug targets to treat human malignancies. These data are reviewed herein.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antigens, CD / genetics
-
Antigens, CD / immunology*
-
Antineoplastic Agents / therapeutic use
-
Bone Marrow Cells / immunology*
-
Bone Marrow Cells / pathology
-
Gene Expression Regulation
-
Humans
-
Immunity, Innate*
-
Intracellular Signaling Peptides and Proteins / genetics
-
Intracellular Signaling Peptides and Proteins / immunology
-
Lymphoproliferative Disorders / genetics
-
Lymphoproliferative Disorders / immunology*
-
Lymphoproliferative Disorders / pathology
-
Multiple Myeloma / drug therapy
-
Multiple Myeloma / genetics
-
Multiple Myeloma / immunology*
-
Multiple Myeloma / pathology
-
Protein Isoforms / antagonists & inhibitors
-
Protein Isoforms / genetics
-
Protein Isoforms / immunology
-
Receptors, Cell Surface / antagonists & inhibitors
-
Receptors, Cell Surface / genetics
-
Receptors, Cell Surface / immunology*
-
Signal Transduction
-
Signaling Lymphocytic Activation Molecule Associated Protein
-
Signaling Lymphocytic Activation Molecule Family Member 1
Substances
-
Antibodies, Monoclonal, Humanized
-
Antigens, CD
-
Antineoplastic Agents
-
Intracellular Signaling Peptides and Proteins
-
Protein Isoforms
-
Receptors, Cell Surface
-
SH2D1A protein, human
-
Signaling Lymphocytic Activation Molecule Associated Protein
-
elotuzumab
-
Signaling Lymphocytic Activation Molecule Family Member 1